Conference Coverage

DDW: SVR rates slump with real world use of sofosbuvir-based HCV regimens


 

AT DDW 2015

References

“I think some of it is people have just gotten really spoiled, and we now think that 95% treatment completion is the real world,” she said. “We just don’t see it. I think one may argue that some of the other supposed real world trials, the TARGET or TRIO trials, those generally are people getting seen at academic medical centers. … Those kinds of centers, although they’re a version of the real world, it’s not quite the same as my nurse practitioner in some of the VA clinics.”

pwendling@frontlinemedcom.com

On Twitter @pwendl

*This story was updated July 1, 2015

Pages

Recommended Reading

DDW: Recurrent C. difficile infections take heavy toll on IBD patients
MDedge Family Medicine
Food recalls highlight risk of listeriosis
MDedge Family Medicine
CDC: Tdap vaccine coverage during pregnancy is low
MDedge Family Medicine
PAS: Use high-dose acyclovir to treat HSV-infected infants
MDedge Family Medicine
FDA warns of possible dosing errors with Zerbaxa
MDedge Family Medicine
Community-level interventions increase HPV immunization rates
MDedge Family Medicine
Inflammatory masses on boy’s scalp
MDedge Family Medicine
Burning pain from chest to back • allodynia and hyperesthesia • extreme sensitivity at the left T5 dermatome • Dx?
MDedge Family Medicine
Prevention measures critical in avoiding global spread of MERS
MDedge Family Medicine
FDA report provides overview of HCV drug approvals
MDedge Family Medicine